Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christoph Bode

Showing results (521-530 of 600) with videos related to

Pageof 60
Sort By:
Lancet (London, England)|September 7, 2012
Stent thrombosis and major clinical events at 3 years after zotarolimus-eluting or sirolimus-eluting coronary stent implantation: a randomised, multicentre, open-label, controlled trialEdoardo Camenzind, William Wijns, Laura Mauri, et al.
European Heart Journal|June 19, 2010
Patients with acute coronary syndromes and elevated levels of natriuretic peptides: the results of the AVANT GARDE-TIMI 43 TrialBenjamin M Scirica, David A Morrow, Christoph Bode, et al.
Frontiers in Endocrinology|January 11, 2020
Dysregulation of the Mitochondrial Proteome Occurs in Mice Lacking Adiponectin Receptor 1Mark E Pepin, Christoph Koentges, Katharina Pfeil, et al.
American Heart Journal|February 15, 2011
A randomized, partially blinded, multicenter, active-controlled, dose-ranging study assessing the safety, efficacy, and pharmacodynamics of the REG1 anticoagulation system in patients with acute coronary syndromes: design and rationale of the RADAR Phase IIb trialThomas J Povsic, Mauricio G Cohen, Roxana Mehran, et al.
Cardiovascular Research|July 9, 2020
Hospital admissions with acute coronary syndromes during the COVID-19 pandemic in German cardiac care unitsThorsten Kessler, Tobias Graf, Ingo Hilgendorf, et al.
Atherosclerosis|November 5, 2017
A molecular intravascular ultrasound contrast agent allows detection of activated platelets on the surface of symptomatic human plaquesAlexander Maier, Patricia Plaza-Heck, Fabian Meixner, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|August 9, 2014
P2Y6 deficiency limits vascular inflammation and atherosclerosis in micePeter Stachon, Alexander Peikert, Nathaly Anto Michel, et al.
International Journal of Cardiology|April 13, 2013
Incidence, treatment, and outcomes of atrial fibrillation complicating non-ST-segment elevation acute coronary syndromesRenato D Lopes, Jennifer A White, Dan Atar, et al.
Nature Medicine|June 23, 2014
Chronic variable stress activates hematopoietic stem cellsTimo Heidt, Hendrik B Sager, Gabriel Courties, et al.
Journal of Thrombosis and Thrombolysis|December 14, 2021
Complement system component dysregulation is a distinctive feature of COVID-19 disease: a prospective and comparative analysis of patients admitted to the emergency department for suspected COVID-19 diseaseNadine Gauchel, Marina Rieder, Krystin Krauel, et al.
Pageof 60

Showing results (521-530 of 600) with videos related to

Sort By:
Pageof 60
Lancet (London, England)|September 7, 2012
Stent thrombosis and major clinical events at 3 years after zotarolimus-eluting or sirolimus-eluting coronary stent implantation: a randomised, multicentre, open-label, controlled trialEdoardo Camenzind, William Wijns, Laura Mauri, et al.
European Heart Journal|June 19, 2010
Patients with acute coronary syndromes and elevated levels of natriuretic peptides: the results of the AVANT GARDE-TIMI 43 TrialBenjamin M Scirica, David A Morrow, Christoph Bode, et al.
Frontiers in Endocrinology|January 11, 2020
Dysregulation of the Mitochondrial Proteome Occurs in Mice Lacking Adiponectin Receptor 1Mark E Pepin, Christoph Koentges, Katharina Pfeil, et al.
American Heart Journal|February 15, 2011
A randomized, partially blinded, multicenter, active-controlled, dose-ranging study assessing the safety, efficacy, and pharmacodynamics of the REG1 anticoagulation system in patients with acute coronary syndromes: design and rationale of the RADAR Phase IIb trialThomas J Povsic, Mauricio G Cohen, Roxana Mehran, et al.
Cardiovascular Research|July 9, 2020
Hospital admissions with acute coronary syndromes during the COVID-19 pandemic in German cardiac care unitsThorsten Kessler, Tobias Graf, Ingo Hilgendorf, et al.
Atherosclerosis|November 5, 2017
A molecular intravascular ultrasound contrast agent allows detection of activated platelets on the surface of symptomatic human plaquesAlexander Maier, Patricia Plaza-Heck, Fabian Meixner, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|August 9, 2014
P2Y6 deficiency limits vascular inflammation and atherosclerosis in micePeter Stachon, Alexander Peikert, Nathaly Anto Michel, et al.
International Journal of Cardiology|April 13, 2013
Incidence, treatment, and outcomes of atrial fibrillation complicating non-ST-segment elevation acute coronary syndromesRenato D Lopes, Jennifer A White, Dan Atar, et al.
Nature Medicine|June 23, 2014
Chronic variable stress activates hematopoietic stem cellsTimo Heidt, Hendrik B Sager, Gabriel Courties, et al.
Journal of Thrombosis and Thrombolysis|December 14, 2021
Complement system component dysregulation is a distinctive feature of COVID-19 disease: a prospective and comparative analysis of patients admitted to the emergency department for suspected COVID-19 diseaseNadine Gauchel, Marina Rieder, Krystin Krauel, et al.
Pageof 60